[Everest Medicines] Announcement regarding the expiration of terms for the first Compensation Committee
Everest Medicines announced that the terms of the members of its first Compensation Committee have expired. New members will be appointed by the board in the next meeting.
📋 Article Processing Timeline
- 📰 Published: May 22, 2026 at 09:00
- 🔍 Collected: May 23, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 24, 2026 at 07:18 (23h 18m after Collected)
1. Date of change: 2026/05/22
2. Functional Committee Name: Compensation Committee
3. Name of outgoing members: (1) Luo Bao-Zhu (2) Yang Pan-Jiang (3) Li Shu-Hui (4) Wang Qi-Ming
4. Background of outgoing members:
(1) Luo Bao-Zhu, Bachelor of Public Finance, National Chung Hsing University (now National Taipei University), Independent Director of Everest Medicines.
(2) Yang Pan-Jiang, Bachelor of Law, National Taiwan University, Independent Director of Everest Medicines.
(3) Li Shu-Hui, Ph.D. in Veterinary Medicine, National Chung Hsing University, Independent Director of Everest Medicines.
(4) Wang Qi-Ming, Master of Management, University of Houston, USA, Independent Director of Everest Medicines.
5. Name of new members: Not yet appointed
6. Background of new members: Not yet appointed
7. Type of change: Expiration of term
8. Reason for change: Expiration of term
9. Former term: 2023/02/17 to 2026/02/16
10. Effective date for new members: New Compensation Committee members will be appointed at the next board meeting.
11. Other remarks: The term of Compensation Committee members is the same as the term of the Board of Directors that appointed them.
2. Functional Committee Name: Compensation Committee
3. Name of outgoing members: (1) Luo Bao-Zhu (2) Yang Pan-Jiang (3) Li Shu-Hui (4) Wang Qi-Ming
4. Background of outgoing members:
(1) Luo Bao-Zhu, Bachelor of Public Finance, National Chung Hsing University (now National Taipei University), Independent Director of Everest Medicines.
(2) Yang Pan-Jiang, Bachelor of Law, National Taiwan University, Independent Director of Everest Medicines.
(3) Li Shu-Hui, Ph.D. in Veterinary Medicine, National Chung Hsing University, Independent Director of Everest Medicines.
(4) Wang Qi-Ming, Master of Management, University of Houston, USA, Independent Director of Everest Medicines.
5. Name of new members: Not yet appointed
6. Background of new members: Not yet appointed
7. Type of change: Expiration of term
8. Reason for change: Expiration of term
9. Former term: 2023/02/17 to 2026/02/16
10. Effective date for new members: New Compensation Committee members will be appointed at the next board meeting.
11. Other remarks: The term of Compensation Committee members is the same as the term of the Board of Directors that appointed them.
FAQ
What does it mean when a Compensation Committee member's term expires?
It means the predetermined period has concluded, necessitating either reappointment or the selection of new members.
Why is this announcement necessary?
Publicly traded companies are required to disclose significant personnel changes or alterations in committee composition to investors.
What is Everest Medicines?
It is a biotechnology company based in Taiwan.